Blue Trust Inc. Has $63,000 Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Blue Trust Inc. decreased its position in DocuSign, Inc. (NASDAQ:DOCU) by 52.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 700 shares of the company’s stock after selling 785 shares during the quarter. Blue Trust Inc.’s holdings in DocuSign were worth $63,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Avior Wealth Management LLC raised its position in DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares during the last quarter. Linden Thomas Advisory Services LLC raised its holdings in shares of DocuSign by 1.1% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock valued at $1,218,000 after purchasing an additional 149 shares during the last quarter. J.W. Cole Advisors Inc. lifted its position in shares of DocuSign by 2.0% in the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after purchasing an additional 155 shares in the last quarter. Optimist Retirement Group LLC boosted its holdings in DocuSign by 3.8% during the third quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after purchasing an additional 161 shares during the last quarter. Finally, Covestor Ltd boosted its holdings in DocuSign by 5.8% during the third quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after purchasing an additional 182 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at DocuSign

In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the transaction, the chief financial officer now owns 77,851 shares in the company, valued at $6,765,251.90. This trade represents a 9.32 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 693,773 shares of company stock valued at $66,727,926 in the last three months. 1.66% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several analyst reports. JPMorgan Chase & Co. boosted their price target on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Tuesday, December 3rd. Jefferies Financial Group lifted their target price on DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Morgan Stanley increased their price target on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Tuesday, February 4th. Finally, Robert W. Baird upped their price objective on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $92.45.

DocuSign Price Performance

Shares of DOCU opened at $83.69 on Tuesday. The firm has a market capitalization of $16.91 billion, a PE ratio of 17.26, a PEG ratio of 6.94 and a beta of 0.89. The company’s 50-day moving average is $91.45 and its 200-day moving average is $77.09. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.